Detalles de la búsqueda
1.
Daratumumab-based regimens for patients with multiple myeloma plus extramedullary plasmacytomas or paraskeletal plasmacytomas: initial follow-up of an Italian multicenter observational clinical experience.
Ann Hematol
; 2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38805036
2.
Carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience of Rete Ematologica Pugliese (REP).
Ann Hematol
; 100(2): 429-436, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33161453
3.
[The role of information and training for workers on the correct use of earplugs in assessing real noise attenuation with E-A-RfitTM system]. / Il peso di in\formazione e formazione dei lavoratori sul correctto utilizzo di inserti auricolari nella valutazione del reale abbattimento del rumore mediante il sistema E-A-Rfit ™.
Med Lav
; 106(4): 284-93, 2015 Jul 08.
Artículo
en Italiano
| MEDLINE | ID: mdl-26154471
4.
Real-world evidence on the use of daratumumab, bortezomib and dexamethasone (DVd) in lenalidomide-refractory myeloma patients: subgroup analysis of the multicenter retrospective experience by "rete ematologica pugliese".
Leuk Lymphoma
; 64(10): 1715-1718, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37417467
Resultados
1 -
4
de 4
1
Próxima >
>>